To find more information on °×С½ãÂÛ̳H Early Phase Cancer Clinical Trials, including eligibility criteria, click theÌýhyperlinkedÌýLocal Project Reference (LRP)ÌýID, which will take you to the °×С½ãÂÛ̳H Find a Study database.
Ìý
ELEVATEA Phase 1b/2, Open-label Umbrella Study to Evaluate Safety and Efficacy of Elacestrant in Various Combinations in Patients with Metastatic Breast Cancer (ELEVATE) | |
---|---|
Local Project Reference: | 158415 |
Principal Investigator | Dr Rebecca Roylance |
Drug Class/ Treatment: | Elacestrant (Estrogen Receptor Antangonist) + Various Combination |
Patient Population: | ER+, HER2– Breast Cancer |
Trial Hosted By - NIHR °×С½ãÂÛ̳H Clinical Research Facility (CRF) |
ELECTRA (ELA-0121)A Phase 2 Study of Magrolimab Combination Therapy in ÌýPatients With Unresectable, Locally Advanced or Metastatic | |
---|---|
Local Project Reference: | |
Principal Investigator | Dr Elisavet Papadimitraki |
Drug Class/ Treatment: | Elacestrant (Oral selective ER degrader) |
Patient Population: | Women and men with brain metastasis from estrogen receptor positive, her-2 negative breast cancer |
Trial Hosted By - NIHR °×С½ãÂÛ̳H Clinical Research Facility (CRF) |
Ìý
Ìý